Home > News > Warburg Research reiterates Nanostart's buy rating
January 21st, 2011
Warburg Research reiterates Nanostart's buy rating
Abstract:
Nanotechnology investor Nanostart (OTCQX: NNS, NASRY) had its 'buy' rating reiterated by equity research firm Warburg Research on Friday, following Nanostart's recent sale and acquisition of various company interests.
Venture investor Nanostart, through its Singapore-based early stage fund, recently sold its stake in Curiox, which it acquired in 2007, earlier than originally expected. According to Nanostart, a small profit was made from the deal, which will flow back into the fund's assets, and will therefore not be distributed as dividends or have a corresponding impact on earnings, said Warburg.
Source:
proactiveinvestors.com
Bookmark:
| Related News Press |
News and information
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Finding quantum order in chaos May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||